VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
163 hedge funds and large institutions have $1.08B invested in Verve Therapeutics in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 74 increasing their positions, 40 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.84% less ownership
Funds ownership: 98.46% → 97.62% (-0.84%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
38% less call options, than puts
Call options by funds: $1.81M | Put options by funds: $2.91M
Holders
163
Holding in Top 10
2
Calls
$1.81M
Puts
$2.91M
Top Buyers
| 1 | +$18.6M | |
| 2 | +$16.3M | |
| 3 | +$12.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$9.66M |
Top Sellers
| 1 | -$13.1M | |
| 2 | -$7.51M | |
| 3 | -$5.63M | |
| 4 |
Jane Street
New York
|
-$3.25M |
| 5 |
Squarepoint
New York
|
-$2.14M |